Aquac. J., Volume 5, Issue 4 (December 2025) – 2 articles

Shrimp farming often suffers due to high mortalities and poor growth. Mycotoxins can be one of the causes but often underestimated. BIŌNTE^® QUIMITŌX^® AQUA PLUS, an anti-mycotoxin additive (AMA) was tested to assess its efficacy and determine the best dose for Pacific white shrimp (Litopenaeus vannamei). Four treatments (0, 1, 2, and 3 g/kg of diet) were randomly allocated in 12 aquaria during larval rearing (day 1–20) and 12 fiberglass tanks during subsequent grow-out (day 21–111). Results showed positive impacts on feed conversion, protein efficiency, survival, and growth. A decreasing trend in FCR and increasing trend in PER with the increase in AMA dose. The higher the dose, the better was the immunity as indicated by the survival of shrimp against bacterial challenge. However, the survival and growth showed significant quadratic relationships indicating that the dose of 1.4 g/kg can have the highest daily weight gain (66.7 mg) and the dose of 2.5 g/kg results in the highest survival (60.3%) which is more than double the survival of the control group (27.3%). Therefore, the doses between 1.4 and 2.5 g/kg of feed are recommended for the grow-out phase to enhance growth and survival of shrimp. However, further studies should be conducted in outdoor pond conditions for varying feeding regimes, contamination levels and stocking densities. Full article

Aquaculture has rapidly become a vital sector for ensuring global food security by meeting the growing demand for animal protein. Bangladesh, one of the world’s leading aquaculture producers, recorded a production of 4.91 million MT in 2022–2023, largely driven by inland farming systems. Despite this remarkable growth, the sector is highly vulnerable to disease outbreaks, which are aggravated by different factors. Pathogens such as bacteria, viruses, fungi, and parasites cause significant losses, while conventional disease diagnosis in Bangladesh still depends mainly on visual assessment and basic laboratory techniques, limiting early detection. This narrative review highlights recent advances in diagnostics as molecular tools, immunodiagnostics, nanodiagnostics, machine learning, and next-generation sequencing (NGS) that are widely applied globally but remain limited in Bangladesh due to infrastructure gaps, lack of skilled manpower, and resource constraints. Current treatment strategies largely rely on antibiotics and aquaculture medicinal products (AMPs), often misused without proper diagnosis, contributing to antimicrobial resistance (AMR). Promising alternatives, including probiotics, immunostimulants, vaccines, and enhanced biosecurity, require greater adoption and farmer awareness. The near-term priorities for Bangladesh include standardized disease and AMR surveillance, prudent antibiotic stewardship, phased adoption of validated rapid diagnostics, and investment in diagnostic and human capacity. Policy-level actions, including a national aquatic animal health strategy, stricter antimicrobial regulation, strengthening diagnostic infrastructure in institution, are crucial to achieve sustainable disease management and ensure long-term resilience of aquaculture in Bangladesh. Full article